Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis.

Abstract:

BACKGROUND AND AIMS

A previous individual patient data meta-analysis (IPD-MA) showed that compared with drugs+endoscopy, the placement of transjugular portosystemic shunt within 72 hours of admission (pre-emptive transjugular intrahepatic portosystemic shunt: p-TIPS) increases the survival of high-risk patients (Child-Pugh B+ active bleeding and Child-Pugh C<14 points) with cirrhosis and acute variceal bleeding. However, the previous IPD-MA was not a two-stage meta-analysis, did not consider the potential risk of selection bias of observational studies, and did not include the most recent randomized clinical trial. We performed an updated and revised IPD-MA to reassess the efficacy of p-TIPS, addressing all previous issues.

APPROACH AND RESULTS

We included all studies from the previous IPD-MA and searched for other possible eligible publications until September 2022. We performed a two-stage IPD-MA of data from 8 studies (4 randomized clinical trials and 4 observational). In addition, we performed a sensitivity analysis excluding those patients dying up to the first 72 hours after admission in the Drugs+Endoscopy arms of the 4 observational studies. The primary end point was the effects of p-TIPS versus Drugs+Endoscopy on 1-year survival.We identified 1389 patients (342 p-TIPS and 1047 Drugs+Endoscopy). The two-stage IPD-MA showed that p-TIPS significantly reduced the mortality in the overall population (HR=0·43, 95% CI: 0.32-0.60, p <0.001. This effect was observed in both subgroups of patients with Child-Pugh. The sensitivity analysis confirmed the survival benefit of p-TIPS.

CONCLUSIONS

The updated two-stage IPD-MA confirms the significant survival advantage of p-TIPS in high-risk patients with cirrhosis and acute variceal bleeding. As a result, we recommend p-TIPS as the preferred first-choice treatment for these patients.

Keywords:

References: de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, et al. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2021;76:1–16.
Monescillo A, Martinez-Lagares F, Ruiz-Del-Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793–801.
García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–9.
Garcia-Pagán JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, et al. Use of early-TIPS for high-risk variceal bleeding : Results of a post-RCT surveillance study. J Hepatol. 2013;58:4–9.
Hernández‐Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, et al. Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study. Hepatology. 2019;69:282–93.
Lv Y, Zuo L, Zhu X, Zhao J, Xue H, Jiang Z, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: A multicentre observational study. Gut. 2018;68:1–14.
Lv Y, Yang Z, Liu L, Li K, He C, Wang Z, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: A randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4:587–98.
Rudler M, Cluzel P, Corvec TL, Benosman H, Rousseau G, Poynard T, et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther. 2014;40:1074–80.
Nicoara-Farcau O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, et al. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding : A meta-analysis of individual patient. Data Gastroenterol. 2021;160:193–205.
Dunne P, Sinha R, Stanley AJ, Lachlan N, Ireland H, Shams A, et al. Randomised clinical trial : Standard of care versus early- transjugular intrahepatic porto-systemic shunt ( TIPSS ) in patients with cirrhosis and oesophageal variceal bleeding. Alimentary Pharm Ther. 2020;52:1–9.
Yadav K, Lewis RJ. Immortal time bias in observational studies. JAMA. 2021;325:686–7.
Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement : An updated guideline for reporting systematic reviews Systematic reviews and Meta-Analyses. BMJ. 2021;372:n71.
Burke DL, Ensor J, Riley RD. Meta-analysis using individual participant data: One-stage and two-stage approaches, and why they may differ. Stat Med. 2017;36:855–75.
Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement. BMJ. 2015;313:1657–65.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2 : A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I : A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: A tool to assess risk of bias and applicability of prediction model studies : Explanation and elaboration. Ann Intern Med. 2019;170:W1–33.
Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.
Fisher DJ. Two-stage individual participant data meta-analysis and generalized forest plots. Stata J. 2015;15:369–96.
Riley RD, Tierney JF, Stewart LA. Individual participant data meta-analysis: A handbook for healthcare research. John Wiley & Sons; 2021.
Stewart GB, Altman DG, Askie LM, Duley L, Simmonds MC, Stewart LA Statistical analysis of individual participant data meta-analyses: A comparison of methods and recommendations for practice.
Bowden J, Tierney JF, Simmonds M, Copas AJ, Higgins JP. Individual patient data meta‐ analysis of time‐to‐event outcomes: One‐stage versus two‐stage approaches for estimating the hazard ratio under a random effects model. Res Synth Methods. 2011;2:150–62.
Shuster JJ. Cochrane handbook for systematic reviews for interventions, Version 5.1. 0, published 3/2011. Julian PT Higgins and Sally Green, Editors.
Riley RD, Simmonds MC, Look MP. Evidence synthesis combining individual patient data and aggregate data: A systematic review identified current practice and possible methods. J Clin Epidemiol. 2007;60:431–9.
Escorsell A, Garcia-Pagán JC, Alvarado-Tapia E, Aracil C, Helena M, Villanueva C, et al. Preemptive TIPS for the treatment of bleeding from gastric fundal varices: Results of a randomized-controlled trial. JHEP Rep. 2023;5:100717.
Dunne P, Finkel J, Khan F, Lachlan N, Patch D, Tripathi D, et al. Effect of time to pre-emptive transjugular intrahepatic portosystemic shunt on patient outcome, a UK multicentre cohort study. Alim Pharm Ther. 2022;57:237–44.

Authors

Wolters Kluwer
Full Text Sources - subscription/membership/fee required

Journal Title: Hepatology (Baltimore, Md.)

Journal ISSN: 1527-3350

Journal ISO Abbreviation: Hepatology

Publication Date: 2023-10-01

DOI: 10.1097/HEP.0000000000000613

Volume:

Issue:

Start Page: